Key guidance on APIs and excipients to aid compliance with EU falsified medicines law
This article was originally published in SRA
Executive Summary
The European Commission has finalized two important and long-awaited guidelines to help pharmaceutical companies comply with the requirements of the EU Falsified Medicines Directive.